Inherited disorders of iron metabolism

Clara Camaschella, Erika Poggiali

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Purpose of Review: To discuss inherited iron disorders, their pathophysiology and clinical implications in the light of the recent advances in our knowledge of iron metabolism and its regulation. RECENT FINDINGS: In previous years the molecular mechanisms of cellular iron uptake and release and the cellular and systemic iron homeostasis have been substantially clarified. New proteins (hepcidin, hemojuvelin, HFE, TFR2 and ferroportin), mutated in hereditary hemochromatosis, have been identified with a crucial role in iron regulation. These advances have modified our understanding of the pathophysiology of hemochromatosis, now considered a disorder either due to hepcidin deficiency or (rarely) due to hepcidin resistance. Novel genetic forms of iron-related microcytic anemia have been identified, due to defects of iron transport/utilization or to TMPRSS6 deficiency and hepcidin hyperproduction, as occurs in iron-refractory iron deficiency anemia (IRIDA). A role for hepcidin has been identified also in acquired conditions, as in iron-loading anemias and in anemia of chronic diseases and inflammation. SUMMARY: Advances in basic research have improved the classification and diagnosis of genetic anemias and iron overload and are paving the way towards the development of drugs that target the molecular lesions.

Original languageEnglish
Pages (from-to)14-20
Number of pages7
JournalCurrent Opinion in Pediatrics
Volume23
Issue number1
DOIs
Publication statusPublished - Feb 2011

Fingerprint

Iron Metabolism Disorders
Hepcidins
Iron
Anemia
Hemochromatosis
Iron Overload
Homeostasis
Chronic Disease
Inflammation

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Inherited disorders of iron metabolism. / Camaschella, Clara; Poggiali, Erika.

In: Current Opinion in Pediatrics, Vol. 23, No. 1, 02.2011, p. 14-20.

Research output: Contribution to journalArticle

Camaschella, Clara ; Poggiali, Erika. / Inherited disorders of iron metabolism. In: Current Opinion in Pediatrics. 2011 ; Vol. 23, No. 1. pp. 14-20.
@article{7d84d258e7bb4ba5ac8800bcb85967e7,
title = "Inherited disorders of iron metabolism",
abstract = "Purpose of Review: To discuss inherited iron disorders, their pathophysiology and clinical implications in the light of the recent advances in our knowledge of iron metabolism and its regulation. RECENT FINDINGS: In previous years the molecular mechanisms of cellular iron uptake and release and the cellular and systemic iron homeostasis have been substantially clarified. New proteins (hepcidin, hemojuvelin, HFE, TFR2 and ferroportin), mutated in hereditary hemochromatosis, have been identified with a crucial role in iron regulation. These advances have modified our understanding of the pathophysiology of hemochromatosis, now considered a disorder either due to hepcidin deficiency or (rarely) due to hepcidin resistance. Novel genetic forms of iron-related microcytic anemia have been identified, due to defects of iron transport/utilization or to TMPRSS6 deficiency and hepcidin hyperproduction, as occurs in iron-refractory iron deficiency anemia (IRIDA). A role for hepcidin has been identified also in acquired conditions, as in iron-loading anemias and in anemia of chronic diseases and inflammation. SUMMARY: Advances in basic research have improved the classification and diagnosis of genetic anemias and iron overload and are paving the way towards the development of drugs that target the molecular lesions.",
author = "Clara Camaschella and Erika Poggiali",
year = "2011",
month = "2",
doi = "10.1097/MOP.0b013e3283425591",
language = "English",
volume = "23",
pages = "14--20",
journal = "Current Opinion in Pediatrics",
issn = "1040-8703",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Inherited disorders of iron metabolism

AU - Camaschella, Clara

AU - Poggiali, Erika

PY - 2011/2

Y1 - 2011/2

N2 - Purpose of Review: To discuss inherited iron disorders, their pathophysiology and clinical implications in the light of the recent advances in our knowledge of iron metabolism and its regulation. RECENT FINDINGS: In previous years the molecular mechanisms of cellular iron uptake and release and the cellular and systemic iron homeostasis have been substantially clarified. New proteins (hepcidin, hemojuvelin, HFE, TFR2 and ferroportin), mutated in hereditary hemochromatosis, have been identified with a crucial role in iron regulation. These advances have modified our understanding of the pathophysiology of hemochromatosis, now considered a disorder either due to hepcidin deficiency or (rarely) due to hepcidin resistance. Novel genetic forms of iron-related microcytic anemia have been identified, due to defects of iron transport/utilization or to TMPRSS6 deficiency and hepcidin hyperproduction, as occurs in iron-refractory iron deficiency anemia (IRIDA). A role for hepcidin has been identified also in acquired conditions, as in iron-loading anemias and in anemia of chronic diseases and inflammation. SUMMARY: Advances in basic research have improved the classification and diagnosis of genetic anemias and iron overload and are paving the way towards the development of drugs that target the molecular lesions.

AB - Purpose of Review: To discuss inherited iron disorders, their pathophysiology and clinical implications in the light of the recent advances in our knowledge of iron metabolism and its regulation. RECENT FINDINGS: In previous years the molecular mechanisms of cellular iron uptake and release and the cellular and systemic iron homeostasis have been substantially clarified. New proteins (hepcidin, hemojuvelin, HFE, TFR2 and ferroportin), mutated in hereditary hemochromatosis, have been identified with a crucial role in iron regulation. These advances have modified our understanding of the pathophysiology of hemochromatosis, now considered a disorder either due to hepcidin deficiency or (rarely) due to hepcidin resistance. Novel genetic forms of iron-related microcytic anemia have been identified, due to defects of iron transport/utilization or to TMPRSS6 deficiency and hepcidin hyperproduction, as occurs in iron-refractory iron deficiency anemia (IRIDA). A role for hepcidin has been identified also in acquired conditions, as in iron-loading anemias and in anemia of chronic diseases and inflammation. SUMMARY: Advances in basic research have improved the classification and diagnosis of genetic anemias and iron overload and are paving the way towards the development of drugs that target the molecular lesions.

UR - http://www.scopus.com/inward/record.url?scp=78751628651&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78751628651&partnerID=8YFLogxK

U2 - 10.1097/MOP.0b013e3283425591

DO - 10.1097/MOP.0b013e3283425591

M3 - Article

C2 - 21150441

AN - SCOPUS:78751628651

VL - 23

SP - 14

EP - 20

JO - Current Opinion in Pediatrics

JF - Current Opinion in Pediatrics

SN - 1040-8703

IS - 1

ER -